Table 2 The list of genes which were downregulated or upregulated by AP treatment that shows statistical significance (P < 0.05) compared to differentiation control performed by NanoString analysis.
Gene symbol | Gene name | Fold change | P value | Gene ID |
|---|---|---|---|---|
HSC stemness | ||||
ADAM10 | Human ADAM metallopeptidase domain | 1.27 | 0.00003 | NM_001110.2 |
ALDH7A1 | Aldehyde dehydrogenase 7 family, member A1 | 1.52 | 0.00017 | NM_001202404.1 |
ALDH9A1 | Aldehyde dehydrogenase 9 family member A1 | 1.23 | 0.00193 | NM_000696.3 |
CD34 | CD34 | 2.06 | 0.00002 | NM_001025109.1 |
GATA3 | GATA binding protein 3 | 2.03 | 0.02395 | NM_001002295.1 |
MEIS1 | Meis homeobox 1 | 1.28 | 0.01317 | NM_002398.2 |
Wnt signaling pathway | ||||
BAMBI | ETS variant 1 | 1.34 | 0.00458 | NM_012342.2 |
CACYBP | Leukemia inhibitory factor | 1.15 | 0.00146 | NM_014412.2 |
CTBP1 | AMP responsive element binding protein 5 | 1.12 | 0.03374 | NM_001328.2 |
CTNNB1 | Transcription factor 7-like 1 | 1.15 | 0.00955 | NM_001098210.1 |
NLK | Kruppel-like factor 4 | 1.21 | 0.00667 | NM_016231.4 |
SKP1 | cAMP responsive element binding protein 3-like 1 | 1.17 | 0.00001 | NM_006930.3 |
TBL1X | Latent transforming growth factor beta binding protein 1 | 1.31 | 0.00029 | NM_005647.4 |
TGFB and SMAD signaling pathway | ||||
LEFTY2 | Phosphoinositide-3-kinase, regulatory subunit 2 | 1.46 | 0.02675 | NM_003240.2 |
NOG | FA complementation group L | 1.48 | 0.03037 | NM_005450.4 |
SMAD2 | Protein kinase C alpha | 1.11 | 0.01511 | NM_001003652.3 |
TGFB1 | Fas (TNF receptor superfamily, member 6) | 1.32 | 0.00059 | NM_000660.3 |
TGFBI | Phosphoinositide-3-kinase, catalytic, beta polypeptide | 1.58 | 0.02251 | NM_000358.2 |
G6PC3 | Phosphoinositide-3-kinase regulatory subunit 3 | 1.27 | 0.00660 | NM_138387.3 |
PRKAG2 | Human protein kinase, AMP-activated, gamma 2 non-catalytic subunit | 1.36 | 0.00358 | NM_016203.3 |
JAK-STAT and AMPK signaling pathway | ||||
JAK1 | Janus kinase 1 | 1.19 | 0.00071 | NM_002227.1 |
PTPN6 | Protein tyrosine phosphatase, non-receptor type 6 | 1.38 | 0.00003 | NM_002831.5 |
SOCS2 | Suppressor of cytokine signaling 2 | 1.58 | 0.00021 | NM_003877.3 |
STAT1 | Signal transducer and activator of transcription 1 | 1.26 | 0.00907 | NM_007315.3 |
DUSP7 | Dual specificity phosphatase 7 | 1.36 | 0.00240 | NM_001947.2 |
FLNB | Filamin B | 1.24 | 0.00080 | NM_001164317.1 |
RASGRP2 | RAS guanyl releasing protein 2 | 1.34 | 0.00204 | NM_001098671.1 |
VEGFC | Vascular endothelial growth factor C | 1.53 | 0.00077 | NM_005429.2 |
Hippo signaling pathway | ||||
LIMD1 | LIM domains containing 1 | 1.12 | 0.02612 | NM_014240.2 |
PARD3 | Par-3 partitioning defective 3 homolog | 1.23 | 0.00138 | NM_019619.2 |
YWHAB | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta | 1.1 | 0.00334 | NM_139323.3 |
YWHAE | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 1.1 | 0.00002 | NM_006761.4 |
YWHAG | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | 1.25 | 0.00445 | NM_012479.4 |
Cell adhesion and ECM | ||||
FYN | FYN related to SRC, FGR, YES | 1.18 | 0.00998 | NM_002037.3 |
ITGA5 | Integrin, alpha 5 | 1.48 | 0.00007 | NM_002205.2 |
RAP1B | RAP1B, member of RAS family | 1.32 | 0.00008 | NM_015646.5 |
ROCK2 | Rho associated coiled-coil containing protein kinase 2 | 1.15 | 0.00045 | NM_004850.3 |
SHC1 | SHC adaptor protein 1 | 1.22 | 0.00476 | NM_001130040.1 |
SRC | Schmidt-Ruppin A-2 | 1.77 | 0.00007 | NM_005417.3 |
TLN1 | Talin 1 | 1.16 | 0.00064 | NM_006289.3 |
FOSL2 | FOS like 2 | 1.35 | 0.00094 | NM_005253.3 |
ITGA2B | Integrin subunit alpha 2b | 1.29 | 0.00130 | NM_000419.3 |
ITGB3 | Integrin subunit beta 3 | 1.27 | 0.00015 | NM_000212.2 |
Cell cycle, cellular senescence, HSC differentiation and cancer related genes | ||||
ATM | ATM | − 1.4 | 0.00005 | NM_000051.3 |
SIRT1 | Sirtuin 1 | − 1.13 | 0.00278 | NM_012238.4 |
SLC25A4 | Solute carrier family 25, member 4 | − 1.21 | 0.04906 | NM_001151.4 |
CACNA2D2 | Calcium channel, voltage-dependent, alpha 2/delta subunit 2 | − 1.65 | 0.00692 | NM_001005505.1 |
E2F5 | E2F transcription factor 5 | − 1.2 | 0.04059 | NM_001083588.1 |
PLCG1 | Phospholipase C gamma 1 | − 1.63 | 0.00110 | NM_002660.2 |
CDH1 | Cadherin 1, type 1, E-cadherin | − 3.23 | 0.00012 | NM_004360.2 |
EPCAM | Epithelial cell adhesion molecule | − 2.14 | 0.00000 | NM_002354.2 |
EXT1 | Exostosin glycosyltransferase 1 | − 1.86 | 0.00366 | NM_000127.2 |
LUM | Lumican | − 2.02 | 0.00963 | NM_002345.3 |
ID2 | Inhibitor of DNA binding 2 | − 1.78 | 0.00003 | NM_002166.4 |
BMPR1A | Bone morphogenetic protein receptor type 1 A | − 3 | 0.00383 | NM_004329.2 |
LDB1 | LIM domain binding 1 | − 1.47 | 0.00005 | NM_001113407.1 |
TGM2 | Transglutaminase 2 | − 2.75 | 0.00007 | NM_004613.4 |
TET1 | Tet methylcytosine dioxygenase 1 | − 1.48 | 0.03371 | NM_030625.2 |
MAF | MAF bZIP transcription factor | − 1.45 | 0.00935 | NM_005360.4 |